VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
KONE Oyj vs Pfizer Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
KONE Oyj
KNEBV · Nasdaq Helsinki
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Pfizer Inc.
PFE · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: KONE Oyj leads (63 / 100 vs 58 / 100 for Pfizer Inc.).
- Segment focus: KONE Oyj has 3 segments (40.6% in New Building Solutions); Pfizer Inc. has 5 segments (47.4% in Primary Care).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Weak vs Moderate.
- Moat breadth: KONE Oyj has 8 moat types across 4 domains; Pfizer Inc. has 8 across 3.
Primary market context
KONE Oyj
New Building Solutions
Elevator, escalator and automatic building door new equipment (new installations)
Global
Property developers and general contractors
OEM + project installation
40.6%
Pfizer Inc.
Primary Care
Branded primary care medicines and vaccines (incl. cardiovascular, migraine, pneumococcal/RSV/COVID-19)
Global
Healthcare providers, payers/PBMs, pharmacies/wholesalers, and government procurement
Innovator biopharma (R&D + manufacturing + commercialization)
47.4%
Side-by-side metrics
Moat coverage
Shared moat types
KONE Oyj strengths
Pfizer Inc. strengths
Segment mix
KONE Oyj segments
Full profile >New Building Solutions
Oligopoly
Service (maintenance & repairs)
Competitive
Modernization
Competitive
Pfizer Inc. segments
Full profile >Primary Care
Oligopoly
Specialty Care
Oligopoly
Oncology
Competitive
Pfizer CentreOne
Competitive
Pfizer Ignite
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.